← FDA Drug Approvals (Drugs@FDA)

ABILIFY ASIMTUFII

NDA · New Drug Application · Sponsor: OTSUKA · Approved 2023-04-27

Drug application

FDA Application #

NDA217006

Application type

New Drug Application

Brand name

ABILIFY ASIMTUFII

Generic name

ARIPIPRAZOLE

Active ingredients

ARIPIPRAZOLE

Dosage form

SUSPENSION, EXTENDED RELEASE

Route

INTRAMUSCULAR

Marketing status

Prescription

Sponsor

OTSUKA

Manufacturer

Otsuka America Pharmaceutical, Inc

First approval

2023-04-27

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown